In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Code Securities: Banking on a Biotech Revival

Executive Summary

When Chris Collins, former head of life sciences at WestLB Panmure, launched Code Securities in November 2003, he was taking a big gamble: biotech deals and IPOs are still at a low ebb, so is investor confidence. Collins is betting on a pick up, hoping that some of Europe's biotechs will see his experienced, dedicated team as a credible, more stable alternative to the bulge bracket banks, many of which were forced to abandon their smaller clients during the downturn.
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel